Ocular Melanoma Research Consortium (OMRC)

Working Groups

The OMRC is comprised of four major working groups that were formed at the October 2009 OMSWG. The international and interdisciplinary working groups focus on issues ranging from tissue banking and OM-specific clinical trials to technology tools to help doctors better communicate.

1. Tissue Banking

Chairs:
Dr. Jacobus Bosch, Dept. of Hematology-Oncology at the University Hospital Erlangen
Dr. Bita Esmaeli, Ophthalmology, MD Anderson Cancer Center

2. Pre-clinical

Chairs:
Dr. Elizabeth Grimm, Deputy Division Head of Research Affairs, MD Anderson Cancer Center
Dr. Martine Jager, Head, Laboratory of Ophthalmology at Leiden University, The Netherlands

3. Clinical Trials

Chairs:
Dr. Keith Flaherty, Medical Oncology, Massachusetts General Hospital
Dr. William Harbour, Ocular Oncology, Washington University
Dr. Takami Sato, Medical Oncology, Thoms Jefferson University

4. Immunology

Chairs:
Dr. F. Stephen Hodi, Medical Oncology, Dana-Farber Cancer Institute
Dr. Bruce Ksander, Department of Ophthalmology, Schepens Eye Research Institute

5. Technology

Chairs:
Dr. Anand Mahadevan, Radiation Oncology, Beth Israel Deaconess Hospital
Mr. Grant Allen, Board Chairman, Ocular Melanoma Foundation/VP, Core Capital

2010: 2nd Annual Scientific Symposium

The 2nd Annual Ocular Melanoma Scientific Research Symposium will be held Fall 2010 at Dana-Farber Cancer Institute in Boston, MA: October 22-23.
Scroll through the calendar and click on a day to see other OMF and OMRC events and meetings.